Posted inHematology-Oncology news
AL-ISS: A New Staging System Identifies an Ultra‑Poor‑Risk Stage (IIIC) in Contemporary AL Amyloidosis
The AL International Staging System (AL-ISS) integrates cardiac biomarkers and echocardiographic longitudinal strain to refine prognosis in systemic AL amyloidosis and define an ultra‑poor‑risk Stage IIIC with median survival of 7 months despite modern therapies.